- Home
- AMOD vs CPIX Comparison
AMOD vs CPIX Comparison
Compare AMOD & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMOD
- CPIX
- Stock Information
- Founded
- AMOD 2014
- CPIX 1999
- Country
- AMOD United States
- CPIX United States
- Employees
- AMOD N/A
- CPIX N/A
- Industry
- AMOD
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- AMOD
- CPIX Health Care
- Exchange
- AMOD NYSE
- CPIX Nasdaq
- Market Cap
- AMOD 42.7M
- CPIX 37.9M
- IPO Year
- AMOD N/A
- CPIX 2009
- Fundamental
- Price
- AMOD $1.89
- CPIX $2.94
- Analyst Decision
- AMOD
- CPIX
- Analyst Count
- AMOD 0
- CPIX 0
- Target Price
- AMOD N/A
- CPIX N/A
- AVG Volume (30 Days)
- AMOD 110.6K
- CPIX 387.1K
- Earning Date
- AMOD 01-01-0001
- CPIX 03-04-2025
- Dividend Yield
- AMOD N/A
- CPIX N/A
- EPS Growth
- AMOD N/A
- CPIX N/A
- EPS
- AMOD N/A
- CPIX N/A
- Revenue
- AMOD N/A
- CPIX $36,785,442.00
- Revenue This Year
- AMOD N/A
- CPIX N/A
- Revenue Next Year
- AMOD N/A
- CPIX N/A
- P/E Ratio
- AMOD N/A
- CPIX N/A
- Revenue Growth
- AMOD N/A
- CPIX N/A
- 52 Week Low
- AMOD $1.70
- CPIX $1.04
- 52 Week High
- AMOD $13.49
- CPIX $3.93
- Technical
- Relative Strength Index (RSI)
- AMOD N/A
- CPIX 63.89
- Support Level
- AMOD N/A
- CPIX $2.21
- Resistance Level
- AMOD N/A
- CPIX $3.93
- Average True Range (ATR)
- AMOD 0.00
- CPIX 0.31
- MACD
- AMOD 0.00
- CPIX -0.01
- Stochastic Oscillator
- AMOD 0.00
- CPIX 22.86
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.